The aim of the present study was to identify specific A v B 3 /A v B 5 integrin antagonists active on tumor-induced angiogenesis. To this purpose, in vitro integrin-binding assays were used to screen a library of conformationally constrained bicyclic lactam Arg-Gly-Asp -containing pseudopeptides. The results identified ST1646 as a high-affinity specific ligand for A v B 3 and A v B 5 integrins with negligible interacting with A 5